The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: A systematic review and meta-analysis

Published:2021-09 Issue:9 Volume:20 Page:102887
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Munguía-Realpozo Pamela,Mendoza-Pinto Claudia,García-Carrasco Mario,Berra-Romani Roberto,Sierra-Benito Cristina,Méndez-Martínez Socorro,Cervera Ricard

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference99 articles.

1. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study;Manzi;Am J Epidemiol,1997

2. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus;Esdaile;Arthritis Rheum,2001

3. Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review;Tselios;J Rheumatol,2016

4. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update;Agca;Ann Rheum Dis,2017

5. Longterm hydroxychloroquine therapy and low-dose aspirin may have an additive effectiveness in the primary prevention of cardiovascular events in patients with systemic lupus Erythematosus;Fasano;J Rheumatol,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on cardiovascular disorders in systemic lupus erythematosus;Advances in Clinical and Experimental Medicine;2024-03-12

2. Seven-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls;Rheumatology;2024-02-06

3. Use of coronarycomputed tomography for cardiovascular risk assessment in immune-mediated inflammatory diseases;Heart;2024-01-18

4. The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus;Rheumatology;2023-04-22

5. Insulin Resistance and Diabetes Mellitus in Patients with Systemic Lupus Erythematosus;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-04